Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catastrophic antiphospholipid syndrome.

Ricard Cervera1, Ronald A Asherson, Josep Font

  • 1Department of Autoimmune Diseases, Hospital Clínic, Villarroel 170, 08036-Barcelona, Catalonia, Spain. rcervera@clinic.ub.es

Rheumatic Diseases Clinics of North America
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pig productive performance parameters and costs in Spain: evolution from 2015 to 2024.

Porcine health management·2026
Same author

An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelators.

Chemical science·2024
Same author

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry").

Seminars in arthritis and rheumatism·2024
Same author

Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation study.

Rheumatology (Oxford, England)·2023
Same author

Correction to: An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences.

Clinical rheumatology·2023
Same author

Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel.

Autoimmunity reviews·2023
Same journal

Rheumatology at the Threshold of Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
See all related articles

Catastrophic Antiphospholipid Syndrome (APS) is a severe condition requiring prompt diagnosis and aggressive treatment. Early detection and preventive strategies are crucial for improving patient outcomes and avoiding mortality.

Area of Science:

  • Immunology
  • Hematology
  • Critical Care Medicine

Background:

  • Catastrophic Antiphospholipid Syndrome (APS) presents a significant mortality risk, necessitating heightened clinical vigilance.
  • Understanding the underlying mechanisms of catastrophic APS requires specialized sample collection and analysis.

Purpose of the Study:

  • To outline the critical need for early diagnosis and aggressive management of catastrophic APS.
  • To establish a framework for sample collection, storage, and dispatch for international research into catastrophic APS mechanisms.

Main Methods:

  • Establishment of an International Registry for catastrophic APS with designated investigation sites in Europe, the US, and Japan.
  • Dissemination of detailed protocols and findings via the International Registry Website.

Related Experiment Videos

Main Results:

  • The study emphasizes the critical importance of early diagnosis and aggressive treatment protocols for catastrophic APS.
  • A collaborative international approach to sample analysis is proposed to advance research into the condition's mechanisms.

Conclusions:

  • Aggressive treatment involving high-dose intravenous heparin, steroids, intravenous gammaglobulins, or plasma exchange is the recommended therapeutic approach.
  • Preventive measures are essential to mitigate the risk of developing catastrophic APS.